More specifically, CB1 receptor activation can result in insulin desensitization and suppressed metabolic activity, whereas inhibition of this same receptor has been shown to attenuate such manifestations of obesity-induced metabolic syndrome (6, 10, 17, 18). The gene discussed is INS; the disease is obesity disorder.